{
    "id": 3264,
    "fullName": "MTOR S2215F",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MTOR S2215F lies within the PI3K/PI4K domain of the Mtor protein (UniProt.org). S2215F confers a gain of function to the Mtor protein resulting in activation of signaling and phosphorylation of downstream targets (PMID: 24631838).",
            "references": [
                {
                    "id": 1953,
                    "pubMedId": 24631838,
                    "title": "A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24631838"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2475,
        "geneSymbol": "MTOR",
        "terms": [
            "MTOR",
            "FRAP",
            "FRAP1",
            "FRAP2",
            "RAFT1",
            "RAPT1",
            "SKS"
        ]
    },
    "variant": "S2215F",
    "createDate": "02/20/2015",
    "updateDate": "02/20/2015",
    "referenceTranscriptCoordinates": {
        "id": 145485,
        "transcript": "NM_004958",
        "gDna": "chr1:g.11124516G>A",
        "cDna": "c.6644C>T",
        "protein": "p.S2215F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8828,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing MTOR S2215F treated with Rapamune (sirolimus) in culture demonstrated decreased phosphorylation of S6k, suggesting sensitivity (PMID: 27482884).",
            "molecularProfile": {
                "id": 3082,
                "profileName": "MTOR S2215F"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6761,
                    "pubMedId": 27482884,
                    "title": "Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27482884"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8824,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing MTOR S2215F and negative for VHL in xenograft models demonstrated sensitivity to treatment with Rapamune (sirolimus), resulting in decreased tumor volume (PMID: 27482884).",
            "molecularProfile": {
                "id": 26459,
                "profileName": "MTOR S2215F VHL neg"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6761,
                    "pubMedId": 27482884,
                    "title": "Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27482884"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3082,
            "profileName": "MTOR S2215F",
            "profileTreatmentApproaches": [
                {
                    "id": 2846,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "MTOR S2215F"
                },
                {
                    "id": 440,
                    "name": "mTOR Inhibitor",
                    "profileName": "MTOR S2215F"
                },
                {
                    "id": 2845,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "MTOR S2215F"
                }
            ]
        },
        {
            "id": 26459,
            "profileName": "MTOR S2215F VHL neg",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 145486,
            "transcript": "XM_005263438",
            "gDna": "chr1:g.11124516G>A",
            "cDna": "c.6644C>T",
            "protein": "p.S2215F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 145485,
            "transcript": "NM_004958",
            "gDna": "chr1:g.11124516G>A",
            "cDna": "c.6644C>T",
            "protein": "p.S2215F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 145487,
            "transcript": "XM_017000900",
            "gDna": "chr1:g.11112893G>A",
            "cDna": "c.6644C>T",
            "protein": "p.S2215F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}